Furthermore, infection of 253G1 cells with HCV-JFH1-tau Lot B1 having M706L mutation was blocked by anti-CLDN6 antibody as well as anti-CD81 and anti-OCLN antibodies (Fig. 6d). Here, MAPT is linked to infection.